Skip to main content
main-content
Top

09-13-2021 | Psychosocial care | News

Peer support enhances lifestyle intervention benefits for new type 2 diabetes

Author:
Eleanor McDermid

medwireNews: People with newly detected type 2 diabetes may gain more from a lifestyle intervention if supported by peers who have had the condition for longer, suggest findings from a randomized trial.

The 432 participants of this trial were screened for prediabetes as part of the previously reported Norfolk Diabetes Prevention Study, but proved to actually have type 2 diabetes, based on paired fasting plasma glucose tests of at least 7.0 mmol/L (126.2 mg/dL) or glycated hemoglobin (HbA1c) tests of at least 48.0 mmol/mol (6.5%).

They were randomly assigned to receive the same lifestyle intervention as used in the main trial, similar to established national diabetes prevention programs, with (n=141) or without (n=142) a peer mentor, or to usual care (n=149).

The intervention group undertook six group sessions over 12 months and then up to 15 maintenance sessions 8 weeks apart. In addition, the mentors made up to 18 motivational telephone calls to their assigned participants (up to seven per mentor), in which they discussed progress and barriers, achievement of goals, and plans of action.

The primary outcome of HbA1c after 12 months was lower in the combined intervention groups than in the control group, but this was significant only in the group with the peer mentors, at 45.6 mmol/mol (6.3%), 46.5 mmol/mol (6.4%), and 48.5 mmol/mol (6.6%) for people with and without mentors and for those in the control group, respectively.

However, these “modest” differences did not persist at 24 months, and so the long-term clinical benefit “is unclear and may not translate to better clinical outcomes,” say Michael Sampson (University of East Anglia, Norwich, UK) and co-researchers.

In subgroup analyses, the effect of the intervention on HbA1c levels was greater in people younger than 65 years than in older people, and in those who were taking oral antidiabetes medications than in those who were not. Again, these benefits were confined to people with a peer mentor.

“The use of trained lay volunteers (with or without diabetes) to support the clinical management of people with type 2 diabetes is an attractive model in terms of workforce planning and limiting cost,” write the researchers in BMC Medicine.

They add: “These findings are relevant to the recent emphasis on community-level interventions and social prescribing through integrated care services or the voluntary sectors.”

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group

BMC Med 2021; 19: 183

ESC Congress 2021 coverage

27 – 30 August: Browse all of the latest coverage


Addressing suicide risk in diabetes

07-14-2021 | Mental health | Feature | Article

Suicide in diabetes: An important but under-recorded problem

How frequent are suicide deaths in people with diabetes, and can the data be trusted?

07-14-2021 | Mental health | Feature | Article

Risk for suicidal ideation: Who, when, and why?

What makes some people more likely than others to have suicidal thoughts? We outline the risk factors and circumstances that can play a role.

07-14-2021 | Mental health | Feature | Article

Creating a safety net: How doctors can help suicidal patients

Screening, emergency protocols, and person-centered care – just some of the ways healthcare professionals can identify and support people at increased risk for suicide. Click through for more.

Suicide risk in diabetes: Why doctors may hesitate to screen, but should not